Targeting neoantigens for cancer immunotherapy.
- Published in:
- International Immunology, 2016, v. 28, n. 7, p. 365, doi. 10.1093/intimm/dxw026
- By:
- Publication type:
- Article
Works matching IS 09538178 AND DT 2016 AND VI 28 AND IP 7
Results: 7
1
2
Chimeric antigen receptor-modified T cells strike back.
- Published in:
- International Immunology, 2016, v. 28, n. 7, p. 353, doi. 10.1093/intimm/dxw018
- By:
- Publication type:
- Article
3
T-cell adoptive immunotherapy using tumor-infiltrating T cells and genetically engineered TCR-T cells.
- Published in:
- International Immunology, 2016, v. 28, n. 7, p. 349, doi. 10.1093/intimm/dxw022
- By:
- Publication type:
- Article
4
Immune checkpoint inhibition in ovarian cancer.
- Published in:
- International Immunology, 2016, v. 28, n. 7, p. 339, doi. 10.1093/intimm/dxw020
- By:
- Publication type:
- Article
5
Vaccine adjuvants as potential cancer immunotherapeutics.
- Published in:
- International Immunology, 2016, v. 28, n. 7, p. 329, doi. 10.1093/intimm/dxw015
- By:
- Publication type:
- Article
6
The present status and future prospects of peptide-based cancer vaccines.
- Published in:
- International Immunology, 2016, v. 28, n. 7, p. 319, doi. 10.1093/intimm/dxw027
- By:
- Publication type:
- Article
7
Introduction: Cancer Immunology Special Issue--Immunotherapy.
- Published in:
- International Immunology, 2016, v. 28, n. 7, p. 317, doi. 10.1093/intimm/dxw028
- By:
- Publication type:
- Article